rBoNT/B1 (Ipsen/Stockholm Univ/Boston Children’s Hosp)

N/A

Report date: 2025/03/20 09:33:17

Base Information

Drug NamerBoNT/B1 (Ipsen/Stockholm Univ/Boston Children’s Hosp)
Drug Alias Namerecombinant BoNT/B1 toxin (Ipsen)
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionNeuromuscular Blocking Agents
TargetsUpdating
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIpsen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesThe Children's Hospital CorpIpsen LtdStockholm University
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A